Shanghai Institute of Hypertension
🇨🇳China
Clinical Trials
6
Active:0
Completed:1
Trial Phases
2 Phases
Phase 4:3
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (60.0%)Not Applicable
2 (40.0%)Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension
Not Applicable
Not yet recruiting
- Conditions
- Chronic Kidney Disease(CKD)Nocturnal Hypertension
- Interventions
- Drug: Antihypertensive treatment with Arotinolol or Amlodipine or ClonidineDrug: Placebo-controlled group
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Shanghai Institute of Hypertension
- Target Recruit Count
- 200
- Registration Number
- NCT06780865
Home Blood Pressure Intervention in the Community Trial
Not Applicable
Recruiting
- Conditions
- Home Blood Pressure
- Interventions
- Drug: Intensive Home BP controlDrug: Standard Home BP control
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Shanghai Institute of Hypertension
- Target Recruit Count
- 10000
- Registration Number
- NCT05858944
- Locations
- 🇨🇳
Community hospitals, Shanghai, Shanghai, China
Registry Study on "Control Nocturnal Hypertension to Reach the Target "
Recruiting
- Conditions
- Nocturnal Hypertension
- First Posted Date
- 2019-10-24
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Shanghai Institute of Hypertension
- Target Recruit Count
- 4500
- Registration Number
- NCT04137549
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- Drug: Placebo of Gastrodia and Uncaria granule
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Shanghai Institute of Hypertension
- Target Recruit Count
- 605
- Registration Number
- NCT04035824
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2014-06-06
- Lead Sponsor
- Shanghai Institute of Hypertension
- Target Recruit Count
- 400
- Registration Number
- NCT02156024
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
- Prev
- 1
- 2
- Next
News
No news found